FMO5 and type 1 diabetes mellitus: To our knowledge, this study is the first to show that in T1DM, the GLP1-RA, liraglutide, exerts its reno-protective effect by regulating TRPC6/NADPH oxidases-DUOX1 and 2 signaling axis.